CHEBI:6538 - loratadine

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name loratadine
ChEBI ID CHEBI:6538
Definition A benzocycloheptapyridine that is 6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine substituted by a chloro group at position 8 and a 1-(ethoxycarbonyl)piperidin-4-ylidene group at position 11. It is a H1-receptor antagonist commonly employed in the treatment of allergic disorders.
Stars This entity has been manually annotated by the ChEBI Team.
Secondary ChEBI IDs CHEBI:94763
Supplier Information
Download Molfile XML SDF
more structures >>
Wikipedia License
Waiting for wikipedia content
Read full article at Wikipedia
Formula C22H23ClN2O2
Net Charge 0
Average Mass 382.890
Monoisotopic Mass 382.14481
InChI InChI=1S/C22H23ClN2O2/c1-2-27-22(26)25-12-9-15(10-13-25)20-19-8-7-18(23)14-17(19)6-5-16-4-3-11-24-21(16)20/h3-4,7-8,11,14H,2,5-6,9-10,12-13H2,1H3
InChIKey JCCNYMKQOSZNPW-UHFFFAOYSA-N
SMILES CCOC(=O)N1CCC(CC1)=C1C2=C(CCC3=C1N=CC=C3)C=C(Cl)C=C2
Roles Classification
Biological Role(s): H1-receptor antagonist
H1-receptor antagonists are the drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine.
cholinergic antagonist
Any drug that binds to but does not activate cholinergic receptors, thereby blocking the actions of acetylcholine or cholinergic agonists.
Application(s): H1-receptor antagonist
H1-receptor antagonists are the drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine.
anti-allergic agent
A drug used to treat allergic reactions.
cholinergic antagonist
Any drug that binds to but does not activate cholinergic receptors, thereby blocking the actions of acetylcholine or cholinergic agonists.
geroprotector
Any compound that supports healthy aging, slows the biological aging process, or extends lifespan.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing loratadine (CHEBI:6538) has functional parent desloratadine (CHEBI:291342)
loratadine (CHEBI:6538) has role anti-allergic agent (CHEBI:50857)
loratadine (CHEBI:6538) has role cholinergic antagonist (CHEBI:48873)
loratadine (CHEBI:6538) has role geroprotector (CHEBI:176497)
loratadine (CHEBI:6538) has role H1-receptor antagonist (CHEBI:37955)
loratadine (CHEBI:6538) is a N-acylpiperidine (CHEBI:48591)
loratadine (CHEBI:6538) is a benzocycloheptapyridine (CHEBI:48593)
loratadine (CHEBI:6538) is a ethyl ester (CHEBI:23990)
loratadine (CHEBI:6538) is a organochlorine compound (CHEBI:36683)
loratadine (CHEBI:6538) is a tertiary carboxamide (CHEBI:140326)
IUPAC Name
ethyl 4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidine-1-carboxylate
INNs Sources
loratadina WHO MedNet
loratadine WHO MedNet
loratadine WHO MedNet
loratadinum WHO MedNet
Synonym Source
4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1-piperidinecarboxylic acid ethyl ester ChEBI
Brand Names Sources
Aerotina ChemIDplus
Alarin ChemIDplus
Alavert DrugBank
Alerpriv ChemIDplus
Allerclear DrugBank
Civerán ChemIDplus
Claratyne ChemIDplus
Claritin KEGG DRUG
Loracert ChemIDplus
Loradamed DrugBank
Loradex ChemIDplus
Lorastine ChemIDplus
Loratyne ChemIDplus
Wal-itin DrugBank
Manual Xrefs Databases
1605 DrugCentral
3820 ChemSpider
D00364 KEGG DRUG
DB00455 DrugBank
FDB023577 FooDB
HMDB0005000 HMDB
Loratadine Wikipedia
LSM-5891 LINCS
View more database links
Registry Numbers Types Sources
4273483 Reaxys Registry Number Reaxys
79794-75-5 CAS Registry Number ChemIDplus
Citations Waiting for Citations Types Sources
15627436 PubMed citation Europe PMC
24134630 PubMed citation Europe PMC
31315424 PubMed citation Europe PMC
31576110 PubMed citation Europe PMC
32312261 PubMed citation Europe PMC
32694422 PubMed citation Europe PMC
32877950 PubMed citation Europe PMC
33550204 PubMed citation Europe PMC
33673552 PubMed citation Europe PMC
33963858 PubMed citation Europe PMC
34121623 PubMed citation Europe PMC
34306392 PubMed citation Europe PMC
7522069 PubMed citation Europe PMC
Last Modified
29 October 2021